As Britain sweltered in the hottest June on record, businesses and homeowners invested in technology to make our living ...

In yesterday’s strategy note, Chester Ntonifor, BCA’s Foreign Exchange and Global Fixed Income Strategist, outlines three trade ideas he expects to outperform this summer. These ideas span the dollar, ...

Approval based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death for the ...

Bengaluru: AstraZeneca is reportedly in discussions with Summit Therapeutics to license an experimental lung cancer drug in a ...

Summit Therapeutics Inc. (NASDAQ: SMMT) is one of the best hot stocks to buy according to Wall Street analysts. On July 3, ...

Other delayed listings include pharmaceutical company Stada and car parts seller Autodoc, both of which have cited either ...

He clarified that his use of the term “hastily” was in reference to the emergency rollout timelines that global health ...

AstraZeneca’s Imfinzi receives European approval to treat patients with resectable muscle-invasive bladder cancer: Cambridge, UK Saturday, July 5, 2025, 09:00 Hrs [IST] AstraZen ...

Taking to social media platform X, the Chief Minister said his remarks were made in response to genuine fears raised by families who had lost loved ones unexpectedly. “I have a duty to respond to the ...

Experts and agencies reject any link between COVID-19 vaccines and sudden cardiac deaths, citing studies showing no causal ...

It comes amid reports that the drugs maker is considering moving its listing from the UK to the US in what would be a hammer ...